A recent report published by
Infinium Global Research on clinical decision support system market provides
in-depth analysis of segments and sub-segments in the global as well as
regional clinical decision support system market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
clinical decision support system market over the short term as well as long
term. The report is a comprehensive presentation of trends, forecasts and dollar
values of global clinical decision support system market. According to the
report, the global clinical decision support system market is projected to grow
at a CAGR of 11.04% over the forecast period of 2020-2026.
Market Insight
Clinical decision support systems
represent a change in outlook in healthcare sector. They minimize analytical
errors by notifying the physician of potentially harmful drug interactions, and
their diagnostic procedures have been shown to enable diagnoses that are more
accurate. There are a wide variety of uses for CDSS in clinical practice such
as assisting with patient-related decision making, determining optimal
treatment strategies for individual patients, supporting general health
policies and estimating treatment outcomes under circumstances where methods
like randomized trials are either impossible or infeasible. Besides that,
growing demand for advanced healthcare information systems and growing
investments by healthcare IT players are expected to drive the demand for
clinical decision support systems.
The outbreak of the COVID-19
crisis has globally strained medical resources and caused significant
mortality. The COVID-19 pandemic has exposed critical gaps in diagnostic
testing and population-level surveillance. Analysts at Infinium Global Research
predict that the market for the global clinical decision support system is
unlikely to be impacted due to the outbreak of the pandemic although the
outbreak of the COVID-19 has strained medical resources and caused significant
mortality for severely and critically ill patients. Presently, the lack of
availability of validated monograms and the machine-learning model to predict
severity risk and triage of affected patients is limited in developing
economies. However, the pandemic has created an increased need for employing CDSS
for risk assessment of patients preferably in a quantitative, non-subjective
way as it is extremely important for patient management and medical resource
allocation, due to which CDSS is expected to gain lucrative growth prospects in
the forecast period. In recent years,
several developed and developing countries have witnessed rapid growth in the
prevalence of chronic diseases along with a rise in the geriatric population.
Moreover, this rise in the disease population will increase the use of
computerized clinical decision support systems to improve chronic disease
management and the processes of chronic care to increase hospital efficiency.
The major factor such as technological advancement in software integration
facilities with other electronic medical record systems and rising prominence
and usage of big data and mhealth tools are expected to fuel the growth of the
clinical decision support system market. However, the high cost of installing CDSS
solutions will hamper market growth. Apart from that, lack of Interoperability,
high maintenance, and service expenses hinders the growth of the clinical
decision support market. Moreover, the emergences of cloud computing and
substantial growth in the number of hospitals and healthcare facilities
adopting several forms of clinical decision support systems in recent times are
some of the factors that provide significant growth opportunities for the
clinical decision support system market in near future. Moreover, the
increasing government initiative, to reform the healthcare sector is likely to
provide new opportunities for the market in upcoming years.
Among the geographies, the North
America region dominates the global clinical decision support system market
owing to increasing investment from healthcare IT players and early adoption by
healthcare services providers. Furthermore, Europe is expected to hold a
significant share in the global clinical decision support system market due to
the availability of advanced technologies across the region. The global
clinical decision support system market in the Asia Pacific region is projected
to witness the fastest growth owing to the rising number of chronic diseases
and rapidly increasing population. Latin America and Middle East & Africa
are likely to expand at a healthy pace in the coming years owing to the rising
emphasis on technological advancements in the healthcare process is likely to
boost demand for the clinical decision support system market in the region
Segment Covered
The report on global clinical
decision support system market covers segments such as system, mode of advice,
application, delivery model, and end-user. On the basis of system, the
sub-markets include knowledge-based systems, expert laboratory information system,
and machine learning systems. On the basis of mode of advice, the sub-markets
include passive CDSS, and active CDSS. On the basis of application, the
sub-markets include drug databases, care plans, diagnostic decision support,
disease reference, and other applications. On the basis of delivery model, the
sub-markets include on-premise, web based, and cloud based. On the basis of
end-user, the sub-markets include hospitals, diagnostic centers, clinics,
retail pharmacy, and others end-user.
Companies Profiled:
The report provides profiles of
the companies in the market such as Siemens Healthineers AG, Koninklijke
Philips N.V., Wolters Kluwer N.V., Cerner Corporation, Abbott Laboratories, GE
Healthcare, OptumHealth LLC, Allscripts Healthcare Solutions Inc., First
Databank Inc., and IBM Watson Health.
Report Highlights:
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of clinical decision support system market. Moreover, the study
highlights current market trends and provides forecast from 2020-2026. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.